Advances in immunotherapies for cancer have spawned new treatments that trigger the immune system to attack the tumor, delivering dramatic benefits to some patients with advanced cancers. Arlene Sharpe and Gordon Freeman share insight from decades of research into pathways that may help lead to a cure.

Arlene Sharpe, MD PhD
George Fabyan Professor of comparative Pathology
Head, Division of Immunology
Interim Co-chari, Dept. of Microbiology and Immunobiology
Harvard Medical School

Gordon Freeman, PhD
Professor of Medicine, HMS
Researcher, Department of Medical Oncology, Dana-Farber

Like Harvard Medical School on Facebook:
Follow on Twitter:
Follow on Instagram:
Follow on LinkedIn:


Leave a Reply

Let us help fight cancer. Share your knowledge.


Latest news, views, insights and trends on cancer treatment, discovery and support